[1] 马锡慧,高钰,韩永等.流式细胞术在肾移植术后感染中的诊断价值[J].器官移植,2018,9(2):137-141,155.
[2] KILDEY K,FRANCIS R S,HULTIN S,et al.Specialized roles of human natural killer cell subsets in kidney transplant rejection[J].Front Immunol,2019,10:1877.
[3] LITTERA R,PIREDDA G,ARGIOLAS D,et al.KIR and their HLA class Ⅰ ligands:two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation[J].PLoS One,2017,12(7):e0180831.
[4] TANG Q,DONG C,SUN Q.Immune response associated with ischemia and reperfusion injury during organ transplantation[J].Inflamm Res,2022, 71(12):1463-1476.
[5] ZHANG Z X,HUANG X,JIANG J,et al.Natural killer cells mediate long-term kidney allograft injury[J].Transplantation,2015,99(5):916-924.
[6] KIM H J,LEE J S,KIM J D,et al.Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation[J].Proc Natl Acad Sci U S A,2012，109(1):E13-22.
[7] LUO L,LU J,WEI L,et al.The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation[J].BMC Cell Biology,2010,11:91.
[8] ZHANG R.Donor-specific antibodies in kidney transplant recipients[J].Clin J Am Soc Nephrol,2018,13(1):182-192.
[9] HIDALGO L G,SIS B,SELLARES J,et al.NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies:evidence for NK cell involvement in antibody-mediated rejection[J].Am J Transplant,2010,10(8):1812-1822.
[10] KOHEI N,TANAKA T,TANABE K,et al.Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts[J].Kidney Int,2016,89(6):1293-1306.
[11] YAGISAWA T,TANAKA T,MIYAIRI S,et al.In the absence of natural killer cell activation donor-specific antibody mediates chronic,but not acute,kidney allograft rejection[J].Kidney Int,2019,95(2):350-362.
[12] VENNER J M,HIDALGO L G,FAMULSKI K S,et al.The molecular landscape of antibody-mediated kidney transplant rejection:evidence for NK involvement through CD16a Fc receptors[J].Am J Transplant,2015,15(5):1336-1348.
[13] PARKES M D,HALLORAN P F,HIDALGO L G.Evidence for CD16a-mediated NK cell stimulation in antibody-mediated Kidney transplant rejection[J].Transplantation,2017,101(4):e102-e111.
[14] TURNER J E,RICKASSEL C,HEALY H,et al.Natural killer cells in kidney health and disease[J].Front Immunol,2019,10:587.
[15] HAMADA S,DUBOIS V,KOENIG A,et al.Allograft recognition by recipient's natural killer cells:molecular mechanisms and role in transplant rejection[J].HLA,2021,98(3):191-199.
[16] O'NEILL M A,HIDALGO L G.NK cells in antibody-mediated rejection—key effector cells in microvascular graft damage[J].Int J Immunogenet,2021,48(2):110-119.
[17] KOENIG A,CHEN C C,MARÇAIS A,et al.Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants[J].Nat Commun,2019,10(1):5350.
[18] KOENIG A,MEZAACHE S,CALLEMEYN J,et al.Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection[J].J Am Soc Nephrol,2021,32(2):479-494.
[19] CALLEMEYN J,SENEV A,COEMANS M,et al.Missing self-induced microvascular rejection of kidney allografts:a population-based study[J].J Am Soc Nephrol,2021,32(8):2070-2082.
[20] DOS SANTOS D C,CAMPOS E F,SARAIVA-CAMARA N O,et al.Compartment-specific expression of natural killer cell markers in renal transplantation:immune profile in acute rejection[J].Transpl Int,2016,29(4):443-452.
[21] DOS SANTOS D C,SARAIVA-CAMARA N O,DAVID D S R,et al.Expression patterns of CD56+ and CD16+ cells in renal transplant biopsies with acute rejection:associations with microcirculation injuries and graft survival[J].Nephrology(Carlton),2017,22(12):993-1001.
[22] KHO M M,BOUVY A P,CADOGAN M,et al.The effect of low and ultra-low dosages thymoglobulin on peripheral T,B and NK cells in kidney transplant recipients[J].Transpl Immunol,2012,26(4):186-190.
[23] DENDLE C,GAN P Y,POLKINGHORNE K R,et al.Natural killer cell function predicts severe infection in kidney transplant recipients[J].Am J Transplant,2019,19(1):166-177.
[24] KAMINSKI H,FISHMAN J A.The cell biology of cytomegalovirus:implications for transplantation[J].Am J Transplant,2016,16(8):2254-2269.
[25] REDONDO-PACHÓN D,CRESPO M,YÉLAMOS J,et al.Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients[J].J Immunol,2017,198(1):94-101.
[26] ATAYA M,REDONDO-PACHÓN D,LLINÀS-MALLOL L,et al.Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients[J].Am J Transplant,2020,20(3):663-676.
[27] SOLEIMANIAN S,YAGHOBI R,KARIMI M H,et al.The direct influence of cytomegalovirus lysate on the natural killer cell receptor repertoire[J].Iran J Allergy Asthma Immunol,2021,20(6):721-733.
[28] MAKWANA N B,FOLEY B,LEE S,et al.Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1(+) NK cells[J].Eur J Immunol,2016,46(11):2597-2608.
[29] FARZAMIKIA N,HEJAZIAN S M,HAGHI M,et al.Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients[J].Immunogenetics,2022,74(2):207-212.
[30] DEBORSKA-MATERKOWSKA D,PERKOWSKA-PTASINSKA A,SADOWSKA-JAKUBOWICZ A,et al.Killer immunoglobulin-like receptor 2DS2(KIR2DS2),KIR2DL2-HLA-C1,and KIR2DL3 as genetic markers for stratifying the risk of cytomegalovirus infection in kidney transplant recipients[J].Int J Mol Sci,2019,20(3):546.
[31] TANGYE S G,PALENDIRA U,EDWARDS E S.Human immunity against EBV-lessons from the clinic[J].J Exp Med,2017,214(2):269-283.
[32] PNG Y T,YANG A Z Y,LEE M Y,et al.The role of NK cells in EBV infection and EBV-associated NPC[J].Viruses,2021,13(2):300.
[33] ALARI-PAHISSA E,ATAYA M,MORAITIS I,et al.NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake[J].PLoS Pathogens,2021,17(8):e1009868.
[34] CHIJIOKE O,MULLER A,FEEDERLE R,et al.Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection[J].Cell Reports,2013,5(6):1489-1498.
[35] JUD A,KOTUR M,BERGER C,et al.Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ[J].Oncotarget,2017,8(4):6130-6141.
[36] VIGIL D,KONSTANTINOV N K,BARRY M,et al.BK nephropathy in the native kidneys of patients with organ transplants:clinical spectrum of BK infection[J].World J Transplant,2016,6(3):472-504.
[37] TRYDZENSKAYA H,JUERCHOTT K,LACHMANN N,et al.The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients[J].Kidney Int,2013,84(2):359-365.
[38] KOVACEVIC-VOJTUSEK I,BUREK-KAMENARIC M,IVKOVIC V,et al.Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients[J].HLA,2019,94(Suppl 2):4-10.
[39] 吴琦,陈孝倩,王天阳,等.KIR基因多态性影响肾移植受者微量巨细胞病毒和BK病毒DNA的研究[J].中国病理生理杂志,2014,30(2):302-307.
[40] TROTTER P,PADLEY J,CRICK K,et al.The role of KIR2DS4 polymorphisms in BK Virus and acute rejection following renal transplantation[J].Transplantation,2018,102:S224.
[41] BUREK-KAMENARIC M,IVKOVIC V,KOVACEVIC-VOJTUSEK I,et al.The role of HLA and KIR immunogenetics in BK virus infection after kidney transplantation[J].Viruses,2020,12(12):1417.
[42] SCHMIDT S,TRAMSEN L,LEHRNBECHER T.Natural killer cells in antifungal immunity[J].Front Immunol,2017,8:1623.
[43] DUGAST E,DAVID G,OGER R,et al.Broad impairment of natural killer cells from operationally tolerant kidney transplanted patients[J].Front Immunol,2017,8:1721.
[44] KESIRAJU S,CH U M,PARITALA P,et al.Unexplained post-renal transplant tolerance:a case report[J].Immunol Res,2016,64(3):791-794.
[45] ZAMIR M R,SHAHI A,SALEHI S,et al.Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation:protectors or opponents?[J].Transplant Rev(Orlando),2022,36(4):100723. |
